Gland Pharma Limited announces resignation of CEO

Mr. Shyamakant Giri, Chief Executive Officer of Gland Pharma Limited, vide his letter dated 24th February, 2026 had resigned from the services of the Company. Upon the recommendation of the Nomination and Remuneration Committee, the Board of Directors had accepted the said resignation today.

Accordingly, Mr. Shyamakant Giri ceases to be the Chief Executive Officer and Key Management Personnel of the Company from close of business hours from April 30, 2026.

The Board of Directors of the Company and the entire Gland Pharma family places on record their sincere appreciation for the leadership and contribution of Mr. Shyamakant Giri as the CEO of the Company.

Shares of Gland Pharma Limited was last trading in BSE at Rs. 1795.10 as compared to the previous close of Rs. 1823.00. The total number of shares traded during the day was 5687 in over 769 trades.

The stock hit an intraday high of Rs. 1800.05 and intraday low of 1700.05. The net turnover during the day was Rs. 10099155.00.

Source : Equity Bulls

Keywords

GlandPharma INE068V01023 Pharmaceuticals Resignation CEO